DarioHealth secured a contract with a Fortune 50 employer to deliver its AI-powered digital cardiometabolic care platform to over 100,000 employees with diabetes and hypertension. The program, launching in Fall 2026, integrates connected devices, personalized coaching, and AI insights to improve chronic condition management. Revenue from this contract will begin by the end of 2026 and grow through 2027. This deal highlights rising demand for integrated health solutions that address multiple chronic diseases simultaneously, aiming to reduce healthcare costs and improve outcomes.
Bank of Hawaii Corporation reported a strong Q2 earnings per share (EPS) of $1.47, surpassing analyst expectations and marking growth from both the previous quarter and last year. However, its revenue of $184.85 million fell short of the estimated $1...
F5, Inc., a leader in application security solutions, will announce its Q2 2026 earnings on July 27 after market close. Revenue is projected at about $834.60 million, up from $780.37 million a year ago, with earnings per share expected around $4.00, ...
State Street Global Advisors & Affiliates disclosed an increase in their holding of DCC plc shares to 1.42%, following recent purchases of 338 shares at €62.85 each and sales of 96 shares at the same price. This disclosure is part of regulatory requi...
Cint has expanded its partnership with Samba to include brand lift measurement for TV campaigns in six additional international markets: Australia, Canada, France, Germany, Italy, and Spain. This expansion allows advertisers to use Samba’s determinis...
Celestica, a key supplier in AI infrastructure, continues to show strong financial performance with a 52.8% revenue increase in Q1 and five consecutive earnings beats. Driven by high demand in its Connectivity and Cloud Solutions segment, the company...
